Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
2,533,454
-
Share change
-
-431,954
-
Total reported value
-
$14,293,000
-
Put/Call ratio
-
3.3%
-
Price per share
-
$5.62
-
Number of holders
-
18
-
Value change
-
-$2,552,773
-
Number of buys
-
10
-
Number of sells
-
9
Institutional Holders of BRIACELL THERAPEUTICS CORP - COM NEW (BCTX) as of Q3 2022
As of 30 Sep 2022,
BRIACELL THERAPEUTICS CORP - COM NEW (BCTX) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,533,454 shares.
The largest 10 holders included
Lynwood Capital Management Inc., K.J. Harrison & Partners Inc, WASATCH ADVISORS INC, Redmond Asset Management, LLC, JANE STREET GROUP, LLC, SABBY MANAGEMENT, LLC, Virtu Financial LLC, Summit Trail Advisors, LLC, Apollon Wealth Management, LLC, and Concord Wealth Partners.
This page lists
18
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.